Israeli and Dutch researchers develop FibrilPaint and FibrilRuler to measure Tau amyloid fibrils in real-time, potentially revolutionizing Alzheimer's diagnostics and drug development.

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

Though there's no such thing as a bad time to exercise, your brain might thank you if you especially commit during these years.

Get insights on Biogen’s Leqembi sales outlook, clinical value, risks, and what new drug approvals may mean for investors.

Sen. Kim's father immigrated from South Korea as a young man, came here and earned a doctorate in genetics. His father's ...

Longer reproductive lifespan, childbirth and extended hormone replacement therapy are associated with lower dementia risk in ...

Scientists often look for early warning signs in the blood called biomarkers. These tiny signals can show changes in the brain even before a person notices memory problems. A new study now shows that ...

A new study shows that components found in aged blood can speed up the buildup of amyloid proteins and alter behavior in an ...

Scientists have identified a small flaw in the enzyme GPX4 that prevents neurons from defending themselves. This mutation, found in children with a rare form of early dementia, disrupts a tiny loop ...

Zahydie Burgos's parents moved into the home she shares with her husband after he was diagnosed with Alzheimer's disease at ...

When the internal rhythm breaks down, these cells no longer work in sync, which may prevent the brain from clearing harmful ...